Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0FV6M
|
|||
| Former ID |
DIB019720
|
|||
| Drug Name |
Deuterium-substituted L-DOPA
|
|||
| Synonyms |
DP-102
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL
|
||
| Formula |
C9H11NO4
|
|||
| Canonical SMILES |
C1=CC(=C(C=C1CC(C(=O)O)N)O)O
|
|||
| InChI |
1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1/i3D2,6D
|
|||
| InChIKey |
WTDRDQBEARUVNC-QZRTVAIESA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Deuterium substitutions in the L-DOPA molecule improve its anti-akinetic potency without increasing dyskinesias. Exp Neurol. 2010 Oct;225(2):408-15. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.